Thu, Jan 18, 2024
On Thursday, Sun Pharma shares ended weaker by Rs 14.3, or 1.1 per cent, at Rs 1,299.3 apiece.
More >
Wed, Jan 17, 2024
Under the terms of the agreement, Bayer has granted non-exclusive rights to Sun Pharma to market and distribute a second Finerenone product under the brand name Lyvelsa. Finerenone was first launched by Bayer under the brand name Kerendia in 2022.
Wed, Jan 03, 2024
Sun Pharma hits a new high after acquiring Israel's Libra Merger, consolidating its presence in the region. This follows a recent US investment in Lyndra Therapeutics. We break down the deals and their potential impact on Sun Pharma's future.
Tue, Dec 15, 2020
Sun Pharma Specialty business is witnessing improved traction. Pick up in the US specialty business coupled with likely traction from a sturdy new product launch pipeline, would fuel the growth of the US business. Moreover, geographic expansion/increasing penetration for specialty portfolios, in markets other than the US, would also aid the growth of specialty portfolios. Healthy growth in chronic therapies along with new launches gaining traction and a possible improvement in acute therapies is likely to fuel growth in the domestic formulations business.
Fri, Dec 11, 2020
Sun Pharmaceutical's efforts around specialty portfolio ramp up are yielding favourable progress as prescription trends around the key products suggest growth on a QoQ basis. Levulan which was significantly below pre COVID levels has broadly normalized but Nirmal Bang says needs to monitor the impact of resurgence in COVID cases. In fact, seeing faint signals of an unfavourable impact of the second COVID wave as trends seems to suggest weakening prescription volumes across product categories in the last week of November.
Mon, Nov 16, 2020
Mid cap companies are moving strongly due to the strong market momentum, however, corrections will he sharper in these markets, so investors and traders should remain cautious. Consumer, Consumption and Auto themes will see good moves in the markets.
Fri, Nov 06, 2020
Two powerful stocks have been revealed that are expected to give spectacular returns on show hosted by Zee Business Managing Editor Anil Singhvi, by Rahul Arora, CEO, Nirmal Bang and Sandeep Wagle, CEO, Sandeep Wagle Advisory Services.
Wed, Nov 04, 2020
Sun Pharma’s Q2 FY21 core PBT beats estimate by 28% driven by healthy revenue growth and cost control. Global specialty product sales rebounded 38% QoQ to U.S. $108 mn with sales of key products Ilymuya, Cequa and Odomzo back at pre Covid-19 levels. CLSA raised their FY21 EPS estimate 39% on back of its big beat Q2 FY21.
Tue, Oct 27, 2020
Jefferies coverage is winning the long term pharma manufacturing game, as shown by new data presented here.
Fri, Oct 09, 2020
CLSA believes that fundamentals for the pharma sector in 2020 are much healthier than even in 2015.
Fri, Aug 21, 2020
Stocks to Buy With Anil Singhvi: Analyst Sanjiv Bhasin today said that Nifty is unlikely to come down to 10,800 levels as per his earlier estimates. He told Zee Business Managing Editor Anil Singhvi that investors must remain cautious and hedge their investments. Investors should protect themselves against all eventualities at all times, the IIFL Director said
Wed, Aug 05, 2020
Stock Market Today: The BSE Sensex shot up 323 points and tested 38,000 mark by touching 38,010 levels. The NSE Nifty also gained 90 points and hit 11,186 mark. Bank Nifty index surged 230 points and hit 21,720 levels.
Thu, Jun 04, 2020
Stocks in Focus on June 4: BPCL, HDFC Life, Aurobindo Pharma, Sun Pharma, etc. are expected to remain newsmakers throughout the intraday trade session.
Fri, Nov 22, 2019
The market snapped its two-day winning run and ended with modest losses on Thursday, November 21, 2019, but stock-specific movements kept the traders busy throughout the day. But certain stocks came in news after the market was closed for trading purposes.
Fri, Sep 06, 2019
On account of positive global markets, DIIs, neutral F&O and negative FIIs, the short-term trend of the Indian markets will be neutral, says Zee Business Managing Editor Anil Singhvi.
Reliance Industries, Sun Pharmaceutical Industries, Bajaj Finance, L&T Finance Holdings and Tech Mahindra are the top 5 stocks that would remain in focus today.
Wed, Sep 04, 2019
On account of positive DIIs, neutral F&O and negative FIIs, the short-term trend of the domestic Indian markets will continue to be negative, says Zee Business Managing Editor Anil Singhvi.
Sun Pharma, Aditya Birla Capital, Edelweiss Financial Services, VST Tillers Tractors and Varun Beverages are the stocks that would remain in focus today.
Fri, Aug 30, 2019
The BSE Sensex scaled 263 points and closed at 37,332 levels while the 50-stock Nifty rose 74 points and regained the psychological 11,000 levels after closing at 11,021 levels.
Stock Market Timing: At a time when Sensex, Nifty has made a breakout, smart investors can pick the given five stocks for their portfolios.
Thu, Aug 29, 2019
Certain stocks came in news after the market was closed yesterday and can have an impact on the market when it reopens on Thursday.
Mon, Jul 15, 2019
The BSE Sensex rose 160 points and closed at 38,896 while Nifty 50 index added 35 points and ended at 11,587 levels.
Wed, Jul 10, 2019
BSE Sensex gained 47 points to 38,777 while the Nifty 50 index went up 9 points to 11,565 levels. Bank Nifty index shot up 131 points to 30,700 levels.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
